Celldex Therapeutics Inc Revenue per Employee (CLDX), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Celldex Therapeutics inc   (NASDAQ: CLDX)
 

Celldex Therapeutics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Celldex Therapeutics Inc 's Revenue per employee fell on a trailing twelve month basis to $ 4,369, but the productivity of Celldex Therapeutics Inc 's employees remained above the company average.
Within the Healthcare sector Celldex Therapeutics inc achieved the highest revenue per employee. While revenue per employee remained unchanged compared to the previous quarter at no. .Celldex Therapeutics Inc has 198 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CLDX Revenue per Employee (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Revenue Change -97.84 % -89.79 % - -70.78 % 345.51 %
Sales per Employee (TTM) $ 4,369 7,803 13,131 29,247 38,177
CLDX's Total Ranking # # # # 3782 # 3746
Seq. Revenue Change -87.5 % - - 5.04 % -40.85 %

CLDX Company Profile >> Back to CLDX Efficiency Comparisons >> Compare CLDX Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry #
Healthcare Sector #
Overall Market #

Revenue per Employee Statistics
High Average Low
$ 77,157 $ 33,078 $ 4,157
(Mar 31 2018)   (Jun 30 2022)



Financial Statements
Celldex Therapeutics Inc 's Revenue MRQ $ 0 Millions Visit CLDX's Income Statement
Celldex Therapeutics Inc 's Revenues TTM $ 1 Millions Visit CLDX's aggregate revenue growth
What are CLDX's Sales? Visit CLDX's Sales by Segment




Other Ratios
Celldex Therapeutics Inc 's Income per Employee
Employees in In Vitro & In Vivo Diagnostic Substances
In Vitro & In Vivo Diagnostic Substances Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
CLDX's Revenue per Employee versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for CLDX's Competitors
Revenue per Employee for CLDX's Suppliers
Revenue per Employee for CLDX's Customers

You may also want to know
CLDX's Sales Growth Rates CLDX's Pe Price to earnings ratio CLDX's Receivables Turnover Ratio CLDX's Stock Quote
CLDX's Net Income Growth Rates CLDX's Ps Price to Sales ratio CLDX's Sales per Employee CLDX's Asset Turnover Ratio
CLDX's Net Margin CLDX's Pb Price to Book ratio CLDX's Financial Strength Ratios CLDX's Dividend Payout Ratio
Date modified: 2026-08-29T17:16:39+00:00




Companies with similar Revenue per Employee for 12 months ending Mar 31 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Mar 31 2026Number of Employees Mar 31 2026
Lightwave Logic Inc   7,150.15 $ 0.243  Million 34 
Aclarion Inc   7,079.91 $ 0.078  Million 11 
Co diagnostics Inc   6,244.92 $ 0.718  Million 115 
Aim Immunotech Inc   4,476.19 $ 0.094  Million 21 
Prokidney Corp   3,848.48 $ 0.889  Million 231 
Pavmed Inc   2,609.76 $ 0.107  Million 41 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.